Nisa Investment Advisors
AKBA icon

Nisa Investment Advisors’s Akebia Therapeutics AKBA Stock Holding History

Nisa Investment Advisors’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.22K Buy
3,033
+78
+3% +$107 ﹤0.01% 2488
2025
Q4 		$4.76K Sell
2,955
-66
-2% -$138 ﹤0.01% 2458
2025
Q3 		$8.25K Hold
3,021
– – ﹤0.01% 2332
2025
Q2 		$11K Buy
3,021
+2,355
+354% +$6.47K ﹤0.01% 2220
2025
Q1 		$1.28K Buy
666
+66
+11% +$135 ﹤0.01% 2576
2024
Q4 		$1.14K Hold
600
– – ﹤0.01% 2650
2024
Q3 		$792 Buy
+600
New +$801 ﹤0.01% 2626
2022
Q2 		– Sell
-1,608
Closed -$1K – 2368
2022
Q1 		$1K Sell
1,608
-354,600
-100% -$759K ﹤0.01% 2350
2021
Q4 		$709K Sell
356,208
-6,000
-2% -$16.4K 0.01% 927
2021
Q3 		$1.04K Hold
362,208
– – 0.01% 894
2021
Q2 		$1.37K Buy
362,208
+20,000
+6% +$67.3K 0.01% 826
2021
Q1 		$1.16K Hold
342,208
– – 0.01% 901
2020
Q4 		$958K Buy
342,208
+335,950
+5,368% +$981K 0.01% 943
2020
Q3 		$16K Buy
6,258
+4,650
+289% +$40.8K ﹤0.01% 2060
2020
Q2 		$22K Buy
1,608
+380
+31% +$3.93K ﹤0.01% 1756
2020
Q1 		$9K Hold
1,228
– – ﹤0.01% 1861
2019
Q4 		$8K Hold
1,228
– – ﹤0.01% 1862
2019
Q3 		$5K Buy
1,228
+850
+225% +$3.64K ﹤0.01% 1892
2019
Q2 		$2K Hold
378
– – ﹤0.01% 1970
2019
Q1 		$3K Hold
378
– – ﹤0.01% 1964
2018
Q4 		$2K Buy
+378
New +$2.96K ﹤0.01% 1905

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nisa Investment Advisors's AKBA Position: Q1 2026 in Review

Nisa Investment Advisors increased its Akebia Therapeutics (AKBA) stake by 2.6% in Q1 2026, buying an estimated $107 and bringing the position to 3,033 shares worth $4.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Nisa Investment Advisors first reported a position in AKBA in Q4 2018 and has held it in 21 quarters since. The position peaked at $958K in Q4 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • Nisa Investment Advisors held 3,033 shares of Akebia Therapeutics worth $4.22K as of Q1 2026.
  • Nisa Investment Advisors bought 78 Akebia Therapeutics shares in Q1 2026, an estimated $107.
  • Akebia Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2488 holding.
  • Nisa Investment Advisors first reported a position in Akebia Therapeutics in Q4 2018 and has held it in 21 quarters since.
  • Nisa Investment Advisors's Akebia Therapeutics position peaked at $958K in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.